Skip to main content

Creative Medical Technology Holdings, Inc. - Common Stock (NQ:CELZ)

0.8722 +0.0222 (+2.61%)
Streaming Delayed Price Updated: 1:26 PM EDT, Jul 14, 2026 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 150,869
Open 0.8700
Bid (Size) 0.8649 (400)
Ask (Size) 0.8795 (17,800)
Prev. Close 0.8500
Today's Range 0.8420 - 0.8796
52wk Range 0.7901 - 6.250
Shares Outstanding 2,580,532
Dividend Yield N/A

Performance

YTD
-55.7%
-55.7%
1 Month
-63.5%
-63.5%
3 Month
-59.8%
-59.8%
6 Month
-57.5%
-57.5%
1 Year
-67.0%
-67.0%

More News

Read More

Frequently Asked Questions

Is Creative Medical Technology Holdings, Inc. - Common Stock publicly traded?
Yes, Creative Medical Technology Holdings, Inc. - Common Stock is publicly traded.
What exchange does Creative Medical Technology Holdings, Inc. - Common Stock trade on?
Creative Medical Technology Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Creative Medical Technology Holdings, Inc. - Common Stock?
The ticker symbol for Creative Medical Technology Holdings, Inc. - Common Stock is CELZ on the Nasdaq Stock Market
What is the current price of Creative Medical Technology Holdings, Inc. - Common Stock?
The current price of Creative Medical Technology Holdings, Inc. - Common Stock is 0.8722
When was Creative Medical Technology Holdings, Inc. - Common Stock last traded?
The last trade of Creative Medical Technology Holdings, Inc. - Common Stock was at 07/14/26 01:26 PM ET
What is the market capitalization of Creative Medical Technology Holdings, Inc. - Common Stock?
The market capitalization of Creative Medical Technology Holdings, Inc. - Common Stock is 2.25M
How many shares of Creative Medical Technology Holdings, Inc. - Common Stock are outstanding?
Creative Medical Technology Holdings, Inc. - Common Stock has 2M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.